Related Experiment Video

Updated: Sep 7, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
10:54

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations

Published on: September 17, 2012

The D-type cyclins and their role in tumorigenesis

G Peters1

  • 1Imperial Cancer Research Fund Laboratories, London, UK.

Journal of Cell Science. Supplement
|January 1, 1994
PubMed

Insights

D-type cyclins regulate cell cycle progression and are implicated in cancer development. Their interaction with Cdk4/Cdk6 may promote tumor growth by affecting tumor suppressor genes like pRb.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • D-type cyclins (cyclin D1, D2, D3) are crucial regulators of the mammalian cell cycle, specifically during the G0/G1 to S phase transition.
  • These cyclins are frequently dysregulated in various cancers, as evidenced by their activation through chromosomal translocations, gene amplification, and retroviral integration in human and mouse models.
  • D-type cyclins form complexes with cyclin-dependent kinases (CDKs), primarily CDK4 and CDK6.

Purpose of the Study:

  • To investigate the role of D-type cyclins in cell cycle regulation.
  • To explore the association between D-type cyclins, CDKs, and tumor suppressor genes in cancer development.
  • To elucidate the mechanism by which D-type cyclins contribute to uncontrolled cell proliferation.

Main Methods:

  • Analysis of D-type cyclin expression during cell cycle progression.
  • Investigation of cyclin D1, D2, and D3 interactions with CDK4 and CDK6.
  • In vitro studies examining the phosphorylation of the retinoblastoma gene product (pRb) by cyclin-CDK complexes.

Main Results:

  • D-type cyclins are expressed during the G0/G1 to S phase transition.
  • Cyclins D1, D2, and D3 preferentially associate with CDK4 and CDK6.
  • These cyclin-CDK complexes are capable of phosphorylating the retinoblastoma gene product (pRb) in vitro.

Conclusions:

  • D-type cyclins play a significant role in cell cycle control.
  • The interaction of D-type cyclins with CDK4/CDK6 is a key event in cell cycle progression.
  • The phosphorylation of pRb by D-type cyclin-CDK complexes suggests a mechanism linking their growth-promoting effects to the modulation of tumor suppressor pathways.

More Related Videos

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia08:14

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia

Published on: July 25, 2017

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...